Buys
Open market- Shares
- Avg price
- Total value
Yat Sun Or - Chief Scientific Officer at ENANTA PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- Chief Scientific Officer
- Issuer ticker
- ENTA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Yat Sun Or in ENANTA PHARMACEUTICALS INC
Sells
Open market- Shares
- -2,390
- Avg price
- $14.23
- Total value
- -$34,010
Net
Past year- Shares
- -2,390
- Share %
- -100%
- Total value
- -$34,010
Reported holdings for Yat Sun Or in ENANTA PHARMACEUTICALS INC
Form 4 holding
Chief Scientific Officer
ENANTA PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 374,854
- Estimated value
- $5,341,669
- Report date
- 12 Feb 2026
- Price
- $14.25
- Ownership
- Direct
Form 4 holding
Chief Scientific Officer
ENANTA PHARMACEUTICALS INC
- Security class
- Stock Option (right to buy)
- Shares / value
- 110,000
- Estimated value
- Report date
- 25 Nov 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Yat Sun Or in ENANTA PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.